Construction of this new EUR100m facility began in 2008 and production is expected to start in 2010. BD is expected to employ approximately 500 people at the facility by 2014.
BD Medical said that the completion of the new manufacturing facility marks an important milestone for it and reinforces its commitment to making quality products available to customers.
Additionally, it is also expected to help meet the growing worldwide demand for the prefillable syringes that are sold to pharmaceutical and biotechnology firms whose injectable drugs are delivered using these devices.
Claude Dartiguelongue, president of BD Medical – Pharmaceutical Systems, said: “BD chose to establish this important production facility in Hungary because of the proximity to the important European customers it will serve. The availability of a highly skilled workforce, access to qualified subcontractors, and the support of local public officials were also key factors in our selection of this attractive location for BD’s new manufacturing presence.”